远大医药(00512.HK)与港大合作 推进抗感染领域创新药研发及落地

阿斯达克财经
Apr 08

远大医药(00512.HK) 公布,集团与香港大学及其全资子公司港大科桥达成战略合作。双方将于学术研究、资源分享、人才培养以及产品开发等方面展开深度合作,合力推进抗感染领域的创新药物研发与成果产业化落地。公司指,本次合作将以创新抗菌药物开发为起点,相关项目由李学臣教授的团队承接,旨在开发具备更优疗效与安全性的全新治疗方案,以解决抗菌治疗领域未被满足的临床需求。后续香港大学将把其拥有的相关知识产授权...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10